To the uninitiated, the term molecular point-of-care (POC) testing might sound like an oxymoron. After all, the science of molecular microbiology is all about detecting targeted bits of microbial … [Read more...]
Inside the Lab Industry
COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million
April 3, 2021
Inside the Lab Industry
COVID-19 Drives Unprecedented but Ultimately Unsustainable Growth
March 5, 2021
As strange as it may sound, the COVID-19 pandemic has driven unprecedented revenue growth in the diagnostics industry. The fourth quarter of 2020 not only continued but accelerated the climb in … [Read more...]
DX Earnings Report
Q3 Creates the Perfect Storm of Sustained COVID-19 Tailwinds and Diminishing Headwinds
December 2, 2020
July through September 2020 was a remarkable quarter for most diagnostics firms. In fact, it was the closest thing to a perfect storm for earnings. Pandemic tailwinds drove massive revenues for firms … [Read more...]
Economic Trends
Labs Lost Less & Will Recover More than Other Healthcare Sectors, Says New Report
October 4, 2020
Although it’s not exactly “Happy Days Are Here Again,” a new S&P report is predicting that the healthcare sector has seen the worst of the COVID-19 pandemic and won’t have to go through “a return … [Read more...]
DX Earnings Report
Q2 Revenues Slide but By Less than Wall Street Expected
September 9, 2020
As expected, the COVID-19 pandemic took a tremendous bite out of lab company earnings in the second quarter. However, the losses were largely below expectations, significantly below in many cases. And … [Read more...]
Test Utilization
Supplies Shortages Continue to Bedevil COVID-19 Testing Efforts
August 12, 2020
What was true at the beginning of the public health emergency remains true today: laboratories simply cannot obtain the supplies they need to deliver desperately needed COVID-19 molecular testing in a … [Read more...]
DX Earnings Report
Strong Q1 Earnings Belie the True Financial Devastation of COVID-19
June 4, 2020
The bad news is that COVID-19 is very, very bad for business; the good news—sort of—is that the pandemic had just the last few weeks of March to wreak havoc on 2020 Q1 earnings reports. And even that … [Read more...]
Market Trends
New Survey Documents Extent of Lab Business Damage Inflicted by COVID-19
June 1, 2020
The fact that the lab business is taking a beating as a result of the COVID-19 pandemic is hardly news. But a recent survey sheds important new light on the extent of the devastation. The Kalorama … [Read more...]
EARNINGS
DX Earnings Report: Lab Market Consolidates but Survivors Stay Strong
December 3, 2019
PAMA and private payor rate cuts and increased market competitiveness are fueling consolidation and driving smaller, independent labs (other than specialty labs) into near extinction. But the big, … [Read more...]
REVENUES
DX Earnings Report: Markets Soften, Payors Harden but Growth Continues
August 26, 2019
Lab business is getting tougher. While PAMA cuts are hurting Medicare revenues, pressure from private payors may be even more intense both at the pricing front end and claims denial back end. Economic … [Read more...]
